Clinical trial NCT00574327 - References

Gastroesophageal Reflux Disease — Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry

Citation(s)

•   Cameron AJ, Lomboy CT
  Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology. 1992 Oct;103(4):1241-5. doi: 10.1016/0016-5085(92)91510-b.
•   Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, Stanford JL, Dubrow R, Schoenberg JB, Mayne ST, Farrow DC, Ahsan H, West AB, Rotterdam H, Niwa S, Fraumeni JF Jr
  Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998 Jan 21;90(2):150-5. doi: 10.1093/jnci/90.2.150.
•   Corley DA, Kerlikowske K, Verma R, Buffler P
  Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology. 2003 Jan;124(1):47-56. doi: 10.1053/gast.2003.50008.
•   El-Serag HB, Aguirre TV, Davis S, Kuebeler M, Bhattacharyya A, Sampliner RE
  Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol. 2004 Oct;99(10):1877-83. doi: 10.1111/j.1572-0241.2004.30228.x.
•   El-Serag HB, Petersen NJ, Carter J, Graham DY, Richardson P, Genta RM, Rabeneck L
  Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004 Jun;126(7):1692-9. doi: 10.1053/j.gastro.2004.03.077.
•   Freedman J, Ye W, Naslund E, Lagergren J
  Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology. 2001 Sep;121(3):548-53. doi: 10.1053/gast.2001.27217.
•   Gray MR, Donnelly RJ, Kingsnorth AN
  The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut. 1993 Jun;34(6):727-31. doi: 10.1136/gut.34.6.727.
•   Gudlaugsdottir S, van Blankenstein M, Dees J, Wilson JH
  A majority of patients with Barrett's oesophagus are unlikely to benefit from endoscopic cancer surveillance. Eur J Gastroenterol Hepatol. 2001 Jun;13(6):639-45. doi: 10.1097/00042737-200106000-00005.
•   Haggitt RC
  Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol. 1994 Oct;25(10):982-93. doi: 10.1016/0046-8177(94)90057-4.
•   Kan T, Shimada Y, Sato F, Maeda M, Kawabe A, Kaganoi J, Itami A, Yamasaki S, Imamura M
  Gene expression profiling in human esophageal cancers using cDNA microarray. Biochem Biophys Res Commun. 2001 Aug 31;286(4):792-801. doi: 10.1006/bbrc.2001.5400.
•   Lagergren J, Bergstrom R, Adami HO, Nyren O
  Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med. 2000 Aug 1;133(3):165-75. doi: 10.7326/0003-4819-133-3-200008010-00007.
•   Lagergren J, Bergstrom R, Lindgren A, Nyren O
  Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999 Mar 18;340(11):825-31. doi: 10.1056/NEJM199903183401101.
•   McDonald ML, Trastek VF, Allen MS, Deschamps C, Pairolero PC, Pairolero PC
  Barretts's esophagus: does an antireflux procedure reduce the need for endoscopic surveillance? J Thorac Cardiovasc Surg. 1996 Jun;111(6):1135-8; discussion 1139-40. doi: 10.1016/s0022-5223(96)70214-3.
•   Moe GL, Kristal AR, Levine DS, Vaughan TL, Reid BJ
  Waist-to-hip ratio, weight gain, and dietary and serum selenium are associated with DNA content flow cytometry in Barrett's esophagus. Nutr Cancer. 2000;36(1):7-13. doi: 10.1207/S15327914NC3601_2.
•   O'Connor JB, Falk GW, Richter JE
  The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol. 1999 Aug;94(8):2037-42. doi: 10.1111/j.1572-0241.1999.01275.x.
•   Rabinovitch PS, Longton G, Blount PL, Levine DS, Reid BJ
  Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables. Am J Gastroenterol. 2001 Nov;96(11):3071-83. doi: 10.1111/j.1572-0241.2001.05261.x.
•   Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS
  Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol. 2000 Jul;95(7):1669-76. doi: 10.1111/j.1572-0241.2000.02196.x.
•   Reid BJ
  Barrett's esophagus and esophageal adenocarcinoma. Gastroenterol Clin North Am. 1991 Dec;20(4):817-34.
•   Romero Y, Cameron AJ, Locke GR 3rd, Schaid DJ, Slezak JM, Branch CD, Melton LJ 3rd
  Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 1997 Nov;113(5):1449-56. doi: 10.1053/gast.1997.v113.pm9352846.
•   Sampliner RE; Practice Parameters Committee of the American College of Gastroenterology
  Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol. 2002 Aug;97(8):1888-95. doi: 10.1111/j.1572-0241.2002.05910.x. No abstract available.
•   Shirvani VN, Ouatu-Lascar R, Kaur BS, Omary MB, Triadafilopoulos G
  Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. Gastroenterology. 2000 Mar;118(3):487-96. doi: 10.1016/s0016-5085(00)70254-x.
•   Souza RF, Morales CP, Spechler SJ
  Review article: a conceptual approach to understanding the molecular mechanisms of cancer development in Barrett's oesophagus. Aliment Pharmacol Ther. 2001 Aug;15(8):1087-100. doi: 10.1046/j.1365-2036.2001.01046.x.
•   Terry P, Lagergren J, Hansen H, Wolk A, Nyren O
  Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev. 2001 Aug;10(4):365-9. doi: 10.1097/00008469-200108000-00010.
•   Trujillo ME, Scherer PE
  Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med. 2005 Feb;257(2):167-75. doi: 10.1111/j.1365-2796.2004.01426.x.
•   van der Burgh A, Dees J, Hop WC, van Blankenstein M
  Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut. 1996 Jul;39(1):5-8. doi: 10.1136/gut.39.1.5.
•   van Sandick JW, van Lanschot JJ, Kuiken BW, Tytgat GN, Offerhaus GJ, Obertop H
  Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut. 1998 Aug;43(2):216-22. doi: 10.1136/gut.43.2.216.
•   Vaughan TL, Davis S, Kristal A, Thomas DB
  Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):85-92.
•   Weston AP, Badr AS, Topalovski M, Cherian R, Dixon A, Hassanein RS
  Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol. 2000 Feb;95(2):387-94. doi: 10.1111/j.1572-0241.2000.01758.x.
•   Weston AP, Sharma P, Mathur S, Banerjee S, Jafri AK, Cherian R, McGregor D, Hassanein RS, Hall M
  Risk stratification of Barrett's esophagus: updated prospective multivariate analysis. Am J Gastroenterol. 2004 Sep;99(9):1657-66. doi: 10.1111/j.1572-0241.2004.30426.x.
•   Wilson KT, Fu S, Ramanujam KS, Meltzer SJ
  Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas. Cancer Res. 1998 Jul 15;58(14):2929-34.
•   Wong A, Fitzgerald RC
  Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. Clin Gastroenterol Hepatol. 2005 Jan;3(1):1-10. doi: 10.1016/s1542-3565(04)00602-0.
•   Younes M, Henson DE, Ertan A, Miller CC
  Incidence and survival trends of esophageal carcinoma in the United States: racial and gender differences by histological type. Scand J Gastroenterol. 2002 Dec;37(12):1359-65. doi: 10.1080/003655202762671215.

A Prospective Study To Define The Role Of Various Factors In Development And Progression Of Gastroesophageal Reflux Disease (GERD) And Barrett's Esophagus And The Creation Of A Registry.

Details for clinical trial NCT00574327